# BioVigilant Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biovigilant-systems

- Industry: Biotechnology
- Headquarters: Tucson, US
- Website: www.biovigilant.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Apr 24, 2006)
- Investors on record: 4

## About

BioVigilant Systems Inc. specializes in advanced microbial detection and monitoring solutions for healthcare and pharmaceutical environments, ensuring high standards of hygiene and safety.BioVigilant Systems Inc. is focused on providing innovative microbial detection technology. The company's headquarters is located in Tucson, US. It was acquired in May 2009 by Yamatake Corporation, part of the azbil Group. The CEO's details are not specified, and there are no noted changes in business strategy or operations. The firm has completed 3 deals to date, with the latest funding round being a Series A in which they raised USD 3.50 mn led by Battelle Ventures, alongside Community Investment Partners, Innovation Valley Partners, and Pearl Street Venture Funds.BioVigilant Systems Inc. offers a range of microbial detection solutions tailored for the healthcare and pharmaceutical sectors. Their flagship products utilize sophisticated technology to monitor microbial contamination, thereby helping institutions maintain compliance with stringent safety regulations. The solutions are designed for easy integration into existing systems, providing real-time data to enhance operational efficiency and safety protocols across various environments. Their products cater specifically to industries that require meticulous hygiene standards, ensuring that clients can effectively manage and mitigate contamination risks.The company's revenue model is built around service agreements and subscription-based offerings for their microbial detection systems. Clients engage with the company through tailored contracts that provide ongoing support and system updates. The pricing structure is designed to accommodate various operational scales, ensuring affordability while delivering high-quality service. With a focus on specialized markets, BioVigilant Systems Inc. maintains a sustainable revenue stream based on the critical needs of healthcare and pharmaceutical clients.BioVigilant Systems Inc. aims to enhance its product offerings by developing next-generation microbial detection systems set for launch in the upcoming years. The company is also planning to expand its market presence in North America and Europe by 2025, leveraging new funding to support these initiatives and enhance their technological capabilities. The funds from the Series A round will be allocated towards research and development, enabling the introduction of innovative solutions that meet the evolving needs of the healthcare sector.

## Funding rounds

- Series A, Apr 24, 2006, $3.5M — Innovation Valley Partners, Battelle Ventures, Pearl Street Venture Funds, Community Investment Partners

## Investors

- Innovation Valley Partners (https://capitalatlas.ai/funds/innovation-valley-partners) — Series A
- Battelle Ventures (https://capitalatlas.ai/funds/battelle-ventures) — Series A
- Pearl Street Venture Funds (https://capitalatlas.ai/funds/pearl-street-venture-funds) — Series A
- Community Investment Partners — Series A